GI & Endoscopy

Here are seven updates on GI companies from the past week:

Positive multitarget stool DNA tests led to more patients undergoing diagnostic colonoscopies and more colorectal neoplasia diagnoses, according to a poster presented at ACG 2018, Oct. 5-10 in Philadelphia.

Takeda is presenting long-term efficacy and real-world data for Entyvio at ACG 2018 in Philadelphia Oct. 5-10.

A single dose of Janssen Pharmaceuticals' Stelara induced clinical remission in patients with moderate to severe ulcerative colitis, according to data presented at the ACG 2018, Oct. 5-10 in Philadelphia.

CDx Diagnostics presented Wide Area Transepithelial Sampling with 3D Tissue Analysis data showing crypt dysplasia played a role in high-grade esophageal dysplasia and esophageal cancer at ACG 18, Oct. 5-10 in Philadelphia.

CSA Medical received $23 million in venture debt and equity financing to advance its pair of cryospray therapies.

Marla C. Dubinsky, MD, is a gastroenterologist at New York City-based Mount Sinai Hospital.

Rochester, Minn.-based gastroenterologist Sunanda Kane, MD, is the American College of Gastroenterology's newly elected president.

More than 40 endoscopists and colorectal surgeons have completed over 500 procedures with Lumendi's visibility-enhancing endoscope accessory, the DiLumen Endolumenal Interventional Platform.

Allergan launched two global clinical research programs for its inflammatory bowel disease drug, brazikumab.